Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
The Beauty Health Company is a global medical aesthetics company focused on skin health, best known for the HydraFacial platform. The company operates at the intersection of professional aesthetics, dermatology, and beauty, providing non-invasive skin health technologies primarily to licensed practitioners. Its core offering is a patented, multi-step facial treatment delivered through proprietary devices and consumables, positioning the company within the professional aesthetic devices and skincare consumables industries.
The company’s business is built around recurring, high-margin consumable sales tied to an installed base of systems, which creates predictable revenue and strong practitioner loyalty. Its primary customers include dermatologists, plastic surgeons, medical spas, aesthetic clinics, and select luxury hospitality partners. The business traces its origins to the development of the HydraFacial technology in the late 1990s, later evolving through private equity ownership and ultimately becoming a publicly traded company in 2021 following a merger with a special purpose acquisition company. Since then, it has focused on scaling the HydraFacial brand globally as a clinically supported, premium skin health platform.
Business Operations
The company generates revenue through three primary business segments: Systems, Consumables, and Services. Systems revenue comes from the sale of HydraFacial delivery devices, while Consumables includes single-use tips, boosters, and serums required for each treatment and represents the largest and most recurring portion of revenue. Services revenue consists of training, support, delivery, and warranty programs provided to practitioners.
Operations span both domestic and international markets, with manufacturing, distribution, and commercial teams supporting a global installed base. The company controls proprietary device technology, treatment protocols, and formulations tied to the HydraFacial ecosystem. Its core operating subsidiary, HydraFacial LLC, manages most commercial and product activities, supported by regional subsidiaries that handle local sales, education, and distribution. Partnerships with skincare brands and practitioners enhance treatment customization and clinical credibility.
Strategic Position & Investments
Strategically, The Beauty Health Company is focused on expanding the global penetration of the HydraFacial platform, increasing utilization within existing accounts, and driving growth through new consumables and treatment enhancements. Growth initiatives include expanding into new clinical indications, investing in practitioner education, and strengthening direct commercial capabilities in key international markets.
The company has made targeted investments to broaden its technology and product portfolio, including acquisitions related to skincare formulations and aesthetic technologies that complement the HydraFacial ecosystem. Its strategy emphasizes science-backed skin health, data-driven treatment personalization, and premium brand positioning rather than high-volume consumer retail distribution. Emerging areas of focus include enhanced digital connectivity of devices, advanced serums, and deeper integration with clinical skincare regimens.
Geographic Footprint
The Beauty Health Company is headquartered in the United States and operates across North America, Europe, Asia-Pacific, Latin America, and the Middle East. North America represents its largest market by revenue, driven by a dense base of aesthetic practices and strong brand recognition among practitioners.
International operations are a key growth driver, with established commercial teams and distributors across EMEA and APAC supporting rapid adoption in markets such as Western Europe, Japan, China, and Australia. The company continues to invest in regional infrastructure, training centers, and localized marketing to expand its global footprint and standardize treatment quality worldwide.
Leadership & Governance
The Beauty Health Company is led by an executive team with experience in medical devices, consumer health, and global brand management. Leadership emphasizes disciplined growth, recurring revenue expansion, and strengthening the company’s position as a category-defining skin health platform within professional aesthetics.
Key executives include:
- Andrew Stanleick – President and Chief Executive Officer
- Dave Callan – Chief Financial Officer
- Ken Weiner – Founder and inventor of the HydraFacial technology
The board and management team oversee corporate governance, capital allocation, and long-term strategy, with a stated focus on innovation, practitioner success, and sustainable global expansion.